The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GM Result, Issue of Equity and Total Voting Rights

21 May 2021 11:14

RNS Number : 4548Z
Location Sciences Group PLC
21 May 2021
 

 

 

21 May 2021

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Result of General Meeting, Issue of Equity and Total Voting Rights

 

 

 

Result of General Meeting

 

The Company is pleased to announce that at its General Meeting held earlier today in connection with the proposed fundraise and Board changes announced on 4 May 2021, all Resolutions were put to the meeting and were duly passed. The voting results from the General Meeting are included at the end of this announcement.

 

Issue of new Ordinary Shares in consideration for cancellation of warrants

 

The Company announces that it has also agreed with the existing warrant holder in the Company to surrender all warrants over Ordinary Shares issued pursuant to the warrant instrument dated 12 December 2016, in consideration for the issue and allotment of 5,000,000 new Ordinary Shares at 0.2 pence per new Ordinary Share in the Company (the "Warrant Cancellation Shares"). The Warrant Cancellation Shares will be issued utilising the Company's existing share authorities put in place at the Company's annual general meeting held on 9 April 2020 and by way of a subscription with the Company.

 

Admission of New Ordinary Shares

 

Application has been made to the London Stock Exchange for 2,017,750,000 new Ordinary Shares, which comprises the Placing Shares, the Subscription Shares, the Fees Shares (excluding 42,500,000 Fees Shares in respect of the second year's fees of the Proposed Directors), the Broker Option Shares and the Warrant Cancellation Shares, to be admitted to trading on AIM. It is anticipated that Admission will occur and that dealings will commence in the New Ordinary Shares at 8.00 a.m. on 25 May 2021.

 

Total Voting Rights

 

Following Admission, the Company will have 2,605,087,398 Ordinary Shares in issue. The Company holds no shares in treasury. Therefore, the Company hereby confirms that the total number of voting rights in the Company will, following Admission, be 2,605,087,398.

 

Shareholders may use this figure of 2,605,087,398 as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

A separate announcement will be made relating to the planned Board changes which will become effective immediately following Admission.

 

A copy of this announcement is available on the Company's website https://www.locationsciencesgroup.ai/investor-relations/rns-news-alerts/.  

 

Terms defined in the circular to shareholders published by the Company on 4 May 2021 shall have the same meanings when used in this announcement.

 

 

For further information please contact:

 

Location Sciences Group PLC via Milk & Honey PR

Mark Slade, Chief Executive Officer

David Rae, CFO and Commercial Director

 

Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656

David Hart

David Worlidge

 

Turner Pope Investments (TPI) Ltd (Placing Agent) Tel: +44 (0)20 3657 0050

James Pope

Andy Thacker

 

Peterhouse Capital (Broker) Tel: +44 (0) 20 7220 9791

Charles Goodfellow

Eran Zucker

 

Milk & Honey PR Tel: +44 (0)20 3637 7310

Kirsty Leighton

Jessica Ballinger

 

 

 

 

No.

Resolution

 

For*

Against

1

To approve the waiver granted by the Panel on Takeovers and Mergers described in the Circular.

91.2%

8.8%

2

To grant the Directors authority to allot equity securities in the Company in the amounts set out in the Notice of General Meeting.

91.2%

8.8%

3

To grant the Directors authority to allot equity securities in the Company for cash as if section 561 of the Act did not apply in the amounts set out in the Notice of General Meeting.

91.2%

8.8%

4

To elect Simon Wilkinson as a Director with effect from Admission.

95.6%

4.4%

5

To elect Dr Nigel Burton as a Director with effect from Admission.

95.6%

4.4%

 

* Includes proxies received to be voted at the discretion of the Chairman.

 

About Location Sciences Group PLC:

 

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMMZGZKGMFGMZM
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.